RETRACTED: Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results

• Published in: Antiviral research 2017-06, Vol.142, p.185-192
• Main Authors: Petrova, Nataliia V., Emelyanova, Alexandra G., Gorbunov, Evgeniy A., Edwards, Michael R., Walton, Ross P., Bartlett, Nathan W., Aniscenko, Julia, Gogsadze, Leila, Bakhsoliani, Eteri, Khaitov, Musa R., Johnston, Sebastian L., Tarasov, Sergey A., Epstein, Oleg I.
• Format: Article
• Language: English
• ISSN: 0166-3542; 1872-9096
• DOI: 10.1016/j.antiviral.2017.03.017

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor in Chief. This article claimed to demonstrate the antiviral activity of ®Anaferon and ®Ergoferon against rhinovirus infection. This report did not reveal that the products tested for antiviral activity were in fact “homeopathically activated form[s] of antibodies,” as described in US patent 8,535,664 B2, submitted by O. I. Epstein and others. Homeopathy is an outmoded form of therapy that is not accepted by modern medical practice and is rejected by modern science. If the manuscript submitted to Antiviral Research had identified the nature of the materials being tested as homeopathic products, it would have been rejected. Now that the Editor in Chief is aware of this information, and has discussed the question extensively with other experts, he has decided to formally retract this article.